New Key Statistics Module, Z-Score and F-Score
SZSE:301166 Key Ratios
Market Cap ¥ M | 2,486.47 |
Enterprise Value ¥ M | 994.42 |
P/E(ttm) | 168.76 |
PE Ratio without NRI | 128.65 |
Forward PE Ratio | -- |
Price/Book | 1.20 |
Price/Sales | 2.11 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 2.11 |
Revenue (TTM) ¥ M | 1,167.00 |
EPS (TTM) ¥ | 0.17 |
Beneish M-Score | -2.27 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -1.20 |
y-y EBITDA Growth Rate % | -120.30 |
EV-to-EBIT | -67.79 |
EV-to-EBITDA | -67.79 |
PEG | -- |
Shares Outstanding M | 86.67 |
Net Margin (%) | 1.21 |
Operating Margin % | -1.01 |
Pre-tax Margin (%) | 0.13 |
Quick Ratio | 9.47 |
Current Ratio | 10.27 |
ROA % (ttm) | 0.60 |
ROE % (ttm) | 0.67 |
ROIC % (ttm) | -13.55 |
Dividend Yield % | 1.61 |
Altman Z-Score | 7.91 |
SZSE:301166 Number of Guru Trades
SZSE:301166 Volume of Guru Trades
Gurus Latest Trades with SZSE:301166
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301166 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Universal Biotech Co Ltd Insider Transactions
No Available Data